Stakes high for GSK in China
“Very difficult and complicated” – GlaxoSmithKline’s description of the corruption affair in China – is an understatement. The tale is messy, basic details are disputed and the Chinese legal system is opaque. But the stakes could hardly be higher for the UK’s biggest pharmaceutical company.
GSK could end up being thrown out of China if allegations of bribery on a colossal scale are accepted by the Chinese courts. Alternatively, GSK could choose to quit the country in disgust if it feels a senior employee, former country head Mark Reilly, has been unfairly convicted in a politically motivated show trial.
Help employers find you! Check out all the jobs and post your resume.
